Search

FDA Reports of Secondary Malignancies Following Chimeric Antigen Receptor (CAR) T Cell Therapies and Relative Risk: an EBMT-EHA-GoCART Coalition Statement

Dec 13 2023

We need to bring your attention to the recent warning disseminated by the Food and Drug Administration (FDA) regarding T-cell lymphomas in patients undergoing Chimeric Antigen Receptor T-cell (CAR-T) therapy (1).

Scientific Meetings

The EHA-SWG Scientific Meetings have been developed as a joint effort of the EHA Specialized Working Groups (SWGs) and EHA to intensify the beneficial collaboration.

Lymphoid malignancies dissected in Warsaw

Apr 18 2017

The EHA–PTHiT Tutorial on Lymphoid Malignancies was held on March 17-18, 2017 in Warsaw, Poland. 96% of meeting attendees were satisfied with the tutorial saying that their expectations are met.

Alliances & partnerships

EHA's approach to policy and regulatory affairs involves collaboration across medical professions and disciplines.

Tutorial on thalassemia focused on best treatment

Jun 10 2018 Posted in Meeting reports Tagged EHA tutorial, thalassemia

Almost 90 delegates from Shiraz and other cities in Iran learned how to identify the best treatment for each thalassemia patient at the EHA-SHRC Hematology Tutorial on Thalassemia on May 10-11, 2018 in Shiraz, Iran.

HemaSphere Editorial Board

Editor-in-Chief
Jan Cools, Belgium
Deputy Editor-in-Chief
Claire Harrison, United Kingdom
Associate Editors
Jeroen Eikenboom, The Netherlands
Simone Ferrero (Italy)
Adele Fielding, United Kingdom
Simon Hallam, United Kingdom
Robert Hills, United Kingdom
Steffen Koschmieder, Germany
Marek Mraz (Czech Republic)
Paula Rodríguez Otero, Spain
Juerg Schwaller, Switzerland

Francesca Vinchi, USA
Scientific Editors
Charles de Bock, Australia
Stephen Hibbs, United…